Personal Profile

Liao Zhengyin

Chief Physician and Professor at the Cancer Center, West China Hospital of Sichuan University;

MD of Sichuan University, Postdoctoral Fellow in Interventional Therapy at the Chinese People's Liberation Army General Hospital;

Master's Supervisor.

Senior Visiting Scholar in Interventional Medicine at Johns Hopkins Hospital, University of Washington Medical Center (USA), and Singapore General Hospital.

Presided over a number of national and provincial/ministerial scientific research projects, with more than 40 academic papers published;

Delivered presentations on the latest interventional therapy achievements at multiple domestic and international interventional medicine conferences.

Academic Appointments

Member, Interventional Medicine Committee, Chinese Medical Doctor Association;

Member, Radioactive Particle Therapy Committee, Chinese Medical Doctor Association;

Member, Ablation Therapy Subcommittee, Interventional Medicine Committee, Chinese Medical Doctor Association;

Member, 4th and 5th Chinese Society of Pain Medicine, Chinese Medical Association;

Deputy Head, Cancer Pain Group, Chinese Society of Pain Medicine, Chinese Medical Association;

Chairman, 3rd Interventional Medicine Committee, Sichuan Medical Association;

Chairman, 1st Minimally Invasive Cancer Therapy Committee, Sichuan Anti-Cancer Association;

Member, Minimally Invasive Cancer Therapy Committee, Chinese Anti-Cancer Association;

Vice Chairman, Pain Medicine Committee, Sichuan Medical Association;

Academic Leader of Sichuan Provincial Health Commission.

Editorial Board Member, Chinese Journal of Interventional Imaging and Therapy;

Editorial Board Member, Chinese Journal of Pain Medicine.

Specialties

Minimally invasive interventional therapy for various tumors, including lung cancer, liver cancer, pancreatic cancer, cholangiocarcinoma, urinary system tumors, etc., with a number of technologies at the leading level both domestically and internationally;

Interventional therapy for complex vascular malformations and hemangiomas;

Interventional treatment for musculoskeletal disorders, cancer pain, uterine fibroids, adenomyosis, various cysts, and other conditions.